Endolastic is at the forefront of revolutionizing endoscopic solutions for some of the most prevalent health challenges of our time: Gastroesophageal Reflux Disease (GERD), obesity, and Type 2 Diabetes. Our innovative technologies, including the ENDOBAND Endoscopic Band-Assisted Gastroplasty (EBG) for obesity management and the Anti-Reflux Band Mucosectomy (ARBM) for GERD treatment, offer minimally invasive alternatives to traditional surgical approaches. These groundbreaking solutions promise to transform patient care by providing safer, more cost-effective, and easily adoptable treatment options.
| Website | https://endolastic.com |
| Employees | 2 (2 on RocketReach) |
| Founded | 2024 |
| Industry | Medical Equipment Manufacturing |
| Keywords | Minimally Invasive Surgery, Medical Devices, Gastrointestinal Health, Bariatric Surgery, Obesity Treatment, Diabetes Technology, Gerd Treatment, Surgical Instruments, Advanced Endoscopy, Innovative Medical Technology, Healthcare Technology, Digestive Health, Weight Loss Solutions, Metabolic Diseases, Surgical Procedures, Medical Innovation, Health Technology, Reflux Disease |
Looking for a particular Endolastic employee's phone or email?
Frederick Haller is the Co-Founder and CEO of Endolastic.
2 people are employed at Endolastic.